Welcome to our dedicated page for Agronomics news (Ticker: AGNMF), a resource for investors and traders seeking the latest updates and insights on Agronomics stock.
Agronomics Ltd reports developments tied to its listed clean-food investment portfolio, including net asset value updates, interim financial results, share issuance, total voting rights and director dealing notifications under UK market-abuse disclosure rules.
Company announcements also describe investments and valuation movements across portfolio companies working in precision fermentation, cultivated seafood, animal-free dairy proteins and related food biotechnology. Recurring items include funding rounds, regulatory clearances, commercial-scale manufacturing initiatives and portfolio company status changes, including orderly wind-downs when an investment is written down.
Agronomics (OTCQB: AGNMF) reported unaudited NAV per share of 13.12 pence as of 31 March 2026, down 4.8% from 13.78 pence at 31 December 2025. Net assets were £138.65 million, with £136.79 million in investments and £1.87 million in cash and deposits.
The share price of 6.32 pence implied a 52% discount to NAV, versus a 12‑month average discount of 50%. NAV movement reflected a £2.1 million FX gain, Solar Foods fair value loss, operating costs, and modest interest income, alongside portfolio fundraises and a commercial product launch.
Agronomics (OTC:AGNMF) is leading a targeted US$10 million Series A-4 financing for portfolio company SuperMeat, with an initial US$6 million raised from Agronomics and affiliates.
Agronomics will invest US$5 million via 26,805,903 new shares at 13.78p, increasing its fully diluted SuperMeat stake to about 27.8%. Total Agronomics investment in SuperMeat will reach approximately £15.2 million. Post-admission, Agronomics’ share count will be 1,083,381,111.
Agronomics (OTC:AGNMF) disclosed that Executive Chair Jim Mellon acquired a total of 3,308,995 ordinary shares between 6 and 12 March 2026 at prices ranging from 6.6p to 7.0p per share.
The purchases raise his combined interest to 165,775,997 shares (15.69% of voting rights). The notification was made under UK Market Abuse Regulation rules and is now public information.
Agronomics Limited (OTC:AGNMF) disclosed that Galloway Limited, an entity indirectly wholly owned by Executive Chair Jim Mellon, acquired a total of 990,000 ordinary shares between 23–25 February 2026 at prices of 6.63–6.65 pence per share.
After these purchases, Jim Mellon’s aggregate interest across closely associated entities is 161,891,217 ordinary shares, representing 15.32% of voting rights. The transaction notification complies with UK Market Abuse Regulation requirements.
Agronomics (OTC:AGNMF) reported unaudited interim results for the six months ending 31 December 2025, recording a net profit of £10,012,753 versus a prior-period loss. NAV per share rose to 13.78p (30 Jun 2025: 12.34p), up 11.7%, while share price closed at 6.2p, a 55% discount to NAV.
Net investment gains were £10.71m; invested assets carrying amount was £137.95m; cash and equivalents were £2.15m. Portfolio and post-period transactions included equity issues to SuperMeat and Blue Nalu, a full write-down of Meatable (£11.9m), and further investment in All G.
Agronomics (OTC:AGNMF) reported an unaudited Net Asset Value (NAV) per share of 13.78p at 31 December 2025, down 5.9% from 14.65p at 30 September 2025, with Net Assets of £140.0m and investments of £138.0m.
The quarter included a full write-off of Meatable (£11.9m), audited fair value movements across several portfolio holdings, issuance of new shares to Supermeat and Blue Nalu, and cash and deposit balances of £2.1m.
Agronomics (OTC:AGNMF) will invest AU$3.0m in All G via a Note Purchase Agreement as part of a minimum AU$10m funding round. Notes carry a 6% coupon, 24‑month maturity and convert to All G shares with a 20% discount if conversion occurs within 18 months or 30% after 18 months. Agronomics will satisfy the consideration by issuing 10,026,375 new ordinary shares at 14.65p per share. Post-transaction Agronomics' All G exposure will be ~£8.9m, ~4.99% of reported NAV (£147.8m). New shares expected admitted on 21 January 2026.
Agronomics (OTC:AGNMF) has subscribed for US$600,000 of Convertible Promissory Notes and purchased 1,012,229 Preferred Shares in BlueNalu for approximately US$6,000,000, satisfied by issuing 30,643,003 Agronomics ordinary shares at 14.65p each.
After the transactions and completion of BlueNalu's CPN round, Agronomics' stake in BlueNalu is expected to be 12.96% fully diluted; Agronomics will hold 2,519,609 Preferred Shares with a book value of ~US$15,540,000. CPNs convert on a qualifying financing (≥US$10m) with a 20% discount or valuation cap. Admission of the new Agronomics shares to AIM is expected on or around 7 January 2026.
Agronomics (OTC:AGNMF) announced on 19 December 2025 that its portfolio company Meatable will be dissolved and all operating activities terminated following a board and shareholder resolution.
The company cited funding shortfalls and other risks during 2025 that prevented continued operations. Agronomics has invested £7.9m in Meatable, previously carried at £11.9m, and will write that investment down to zero. The write-off represented approximately 8.10% of Agronomics' NAV as at 30 September 2025. The wind-down will follow statutory liquidation procedures.
Agronomics (OTC:AGNMF) announced that portfolio company Liberation Bioindustries closed the first tranche of its Series A1 equity round on 19 December 2025.
Liberation is constructing a 600,000‑liter commercial precision‑fermentation facility to produce protein and bio‑based ingredients. Agronomics converted its convertible loan notes into Series A1 shares, increasing its A1 shareholding from 6,834,147 to 16,538,437. Agronomics has invested US$27.0m to date; the investment is now carried at US$46.8m (c. £35m), a recorded uplift of US$2.5m. The position represents approximately 23% of Agronomics' net asset value as of 30 Sep 2025. New Agrarian Company will invest US$2.5m in the round.